NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%
NIFTY24,173.050.84%
SENSEX77,664.001.09%
BANKNIFTY56,305.001.43%
NIFTY IT30,124.301.22%
PHARMA22,986.352.36%
AUTO25,828.102.35%
FMCG51,140.500.11%
METAL12,786.250.82%
REALTY788.651.83%
ENERGY39,996.750.25%

Indian Equity Markets Extend Losing Streak for Second Consecutive Session

On April 23, the Indian equity markets continued their downward trend, following a lack of progress in US–Iran negotiations that pushed crude oil prices above $100 per barrel. This development dampened investor sentiment, leading to a weak market performance.

The market started the session on a negative note, with the Nifty slipping to an intraday low of 24,134.80. The decline was driven by selling in auto, IT, and realty stocks, as well as weakness in the broader indices. At close, the Sensex was down 852.49 points or 1.09 percent at 77,664, while the Nifty was down 205.05 points or 0.84 percent at 24,173.05.

Sectoral Performance

Read also: Reliance Industries Q4 Earnings Preview: Analysts Anticipate Steady Performance Amid O2C Volatility and Telecom Growth

The sectoral front saw mixed performance, with some sectors gaining while others declined. The capital goods index gained 0.4%, while the healthcare index rose 1.6%. The energy index also gained 0.25%, and the media index surged 0.9%. On the other hand, the auto, consumer durables, and PSU Bank indices declined 2% each, while the IT, realty, metal, and private bank indices declined 1% each.

Biggest Losers and Gainers

The biggest losers on the Nifty were Trent, M&M, Shriram Finance, SBI Life Insurance, and Tech Mahindra. In contrast, the biggest gainers were Dr Reddy's Labs, Cipla, Jio Financial, Adani Enterprises, and Apollo Hospitals.

Stock-Specific Action

Read also: Adani Energy Solutions Reports 5.7% Increase in Q4 Net Profit to Rs 684 Crore

Some stocks witnessed significant price movements, driven by various factors. Tips Music shares gained 9% after its Q4 net profit jumped 93%. Jio Financial Services also gained 4% after signing an agreement with Allianz Group to form an insurance joint venture. Cipla shares surged nearly 6% following USFDA approval for the first AB-rated generic of Ventolin HFA.

On the downside, L&T Technology Services slipped nearly 3% despite reporting better-than-expected Q4 earnings. KP Energy jumped 3.5% after receiving an inter-state electricity trading licence. Tata Communications added nearly 5% despite a 74% decline in Q4 consolidated profit.

Outlook for April 24

Technical analysts predict a bearish trend for the Nifty, with the zone of 24,080–24,050 acting as immediate support. A break below 24,050 may lead the index towards the 23,940–23,900 zone. On the upside, 24,300–24,330 remains a key resistance area.

SectorPrevious Day's PerformanceToday's Performance
Capital Goods0.4% gain0.4% gain
Healthcare1.5% gain1.6% gain
Energy0.2% gain0.25% gain
Media0.8% gain0.9% gain
Auto2% decline2% decline
Consumer Durables2% decline2% decline
PSU Bank2% decline2% decline
IT1% decline1% decline
Realty1% decline1% decline
Metal1% decline1% decline
Private Bank1% decline1% decline

Investor Takeaway

Investors should be cautious and consider diversifying their portfolios due to the current market downturn.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.